TotalMarketCap

Anixa Biosciences

ANIXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$104.987 M

$3.02 -7.93%

Close of 6 Nov 2026

As of 6 Nov 2026, Anixa Biosciences (ANIX) has a market capitalization of $105.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$210.0K

#3546 by revenue

Earnings

-$10.9M

Loss-making

Shares outstanding

34,763,802

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #284Kazia TherapeuticsKZIA$109.7M
  2. #285OrganogenesisORGO$107.9M
  3. #286Anixa BiosciencesANIX$105.0M
  4. #287NovaBridge BiosciencesNBP$104.8M
  5. #288TuHURA BiosciencesHURA$103.9M

What if Anixa Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$812,249.30

Per share 268,957× higher

Bitcoin $1.53T

$43,949.40

Per share 14,553× higher

Apple $5.02T

$144,281.76

Per share 47,775× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Anixa Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.